Announcement on Appointment of Deputy General Manager
Filed with SSE · · 2 pages · Chinese
Zhejiang Chengyi Pharmaceutical Co. Ltd. on 6ix
Earlier from Zhejiang Chengyi Pharmaceutical
- Announcement on Retirement and Resignation of Senior Management Member
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
- Announcement on Abnormal Fluctuations in Stock Trading
- Announcement on Progress in Repurchasing Shares through Call Auction
- Announcement on the Acquisition of Drug Registration Certificate for Peramivir Injection
Later from Zhejiang Chengyi Pharmaceutical
- Announcement on Obtainment of Drug Registration Certificate for Icosapent Ethyl Soft Capsules
- Announcement on the Company's Drug Passing Consistency Evaluation of Generic Drug
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
- Announcement on Resolutions of the 1st Holders' Meeting for 2025 Employee Stock Ownership Plan
- Announcement on Completion of Non-trading Transfer under the 2025 Employee Stock Ownership Plan
Follow Zhejiang Chengyi Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Chengyi Pharmaceutical